Cargando…

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis

Portal venous system thrombosis (PVST), a common complication of liver cirrhosis, is closely associated with thrombophilia. To explore the association of homocysteine (Hcy), anticardiolipin antibody (aCL), and anti-β2 glycoprotein I antibody (aβ(2)GPI), which are possible thrombophilic factors, with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Le, Guo, Xiaozhong, Xu, Xiangbo, Xu, Shixue, Han, Juqiang, Wang, Ran, Guo, Zeqi, Yi, Fangfang, Qi, Xingshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072837/ https://www.ncbi.nlm.nih.gov/pubmed/33882699 http://dx.doi.org/10.1177/10760296211010969

Ejemplares similares

Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis
por: He, Yanglan, et al.
Publicado: (2021)

Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study
por: Xu, Xiangbo, et al.
Publicado: (2020)

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis
por: Zhang, Yiyan, et al.
Publicado: (2023)

Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case–control study
por: Wang, Le, et al.
Publicado: (2022)

No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis
por: Zheng, Kexin, et al.
Publicado: (2020)

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis
por: Wang, Le, et al.
Publicado: (2020)

Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review
por: Xu, Shixue, et al.
Publicado: (2021)

Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
por: Dai, Junna, et al.
Publicado: (2015)

Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: A Meta-Analysis
por: Qi, Xingshun, et al.
Publicado: (2014)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
por: Kang, H. J., et al.
Publicado: (1998)

Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients
por: Qi, Xingshun, et al.
Publicado: (2016)

Advances in the Research on Anticardiolipin Antibody
por: Wang, Dan, et al.
Publicado: (2019)

Association of anticardiolipin antibodies with epilepsy in children
por: Shiva, Shadi, et al.
Publicado: (2023)

Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
por: Melayah, Sarra, et al.
Publicado: (2022)

Anticardiolipin and/or anti-β2-glycoprotein-I antibodies are associated with adverse IVF outcomes
por: Wu, Li, et al.
Publicado: (2022)

Low frequency of phosphatidylserine/prothrombin complex antibodies in a cohort of patients with anticardiolipin antibodies and recent thrombosis
por: Locht, H
Publicado: (2003)

Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature
por: Qi, Xingshun, et al.
Publicado: (2015)

Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19
por: Garcia-Arellano, Gisela, et al.
Publicado: (2023)

Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies
por: Qi, Xingshun, et al.
Publicado: (2015)

Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
por: Vanoverschelde, Laura, et al.
Publicado: (2019)

Frequency and significance of anticardiolipin antibodies in Chinese patients with primary Sjögren's syndrome
por: Bo, Li, et al.
Publicado: (2008)

Prevalence of Anticardiolipin Antibodies in Pregnancies with History of Repeated Miscarriages
por: Spegiorin, Ligia Cosentino Junqueira Franco, et al.
Publicado: (2010)

Clinically significant anticardiolipin antibodies associated with COVID-19
por: Hossri, Sami, et al.
Publicado: (2020)

Idiopathic hypertrophic pachymeningitis with anticardiolipin antibody: A case report
por: Wu, Chi-Shun, et al.
Publicado: (2021)

Prevalence and coagulation correlation of anticardiolipin antibodies in patients with COVID-19
por: Zeng, Hui, et al.
Publicado: (2022)

Anticardiolipin Antibodies in Patients with Cancer: A Case–Control Study
por: Nipu, Md. Ashraful Islam, et al.
Publicado: (2023)

Risk Factors for Esophageal Collateral Veins in Cirrhosis with and without Previous Endoscopic Esophageal Variceal Therapy
por: Li, Qianqian, et al.
Publicado: (2022)

Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Lin, Hanyang, et al.
Publicado: (2022)

Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report: Anticardiolipin antibody and myocardial infarction
por: Su, Xin, et al.
Publicado: (2019)

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface
Publicado: (1994)

Associations of Antiphospholipid Antibodies With Splanchnic Vein Thrombosis: A Systematic Review With Meta-Analysis
por: Qi, Xingshun, et al.
Publicado: (2015)

An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty
por: Qi, Xingshun, et al.
Publicado: (2016)

Multiple Recurrent Stent Thrombosis in a Patient with Coexisting Clopidogrel Resistance and Increased Anticardiolipin Antibodies: A Case Report
por: Middlebrooks, Erik H., et al.
Publicado: (2010)

Clinical significance of neutrophil extracellular traps biomarkers in thrombosis
por: Xu, Xiangbo, et al.
Publicado: (2022)

Spontaneous Resolution of Portal Vein Thrombosis in Cirrhosis: Where do we Stand, and Where will we Go?
por: Qi, Xingshun, et al.
Publicado: (2014)

No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis
por: An, Yang, et al.
Publicado: (2020)

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
por: Li, Miaomiao, et al.
Publicado: (2020)

Hyperoside Protects Human Umbilical Vein Endothelial Cells Against Anticardiolipin Antibody-Induced Injury by Activating Autophagy
por: Wei, Aiwu, et al.
Publicado: (2020)

A Rare Case of Coronary Artery Thrombosis in a Patient With Recently Diagnosed Giant Cell Arteritis: Is Anticardiolipin Antibody Involved?
por: Shan, Khine S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mhfvcqchkm4f2qcmkcgsjou4s2